Beauty Health (NASDAQ:SKIN) Stock Price Down 1.1% - Here's What Happened

Key Points

• Beauty Health (NASDAQ:SKIN) dropped 1.1% to $0.9215 on Thursday, trading as low as $0.9003 with about 289,935 shares changing hands — roughly 58% below its average daily volume.
• Sell‑side consensus is a "Hold" (1 Buy, 6 Hold, 1 Sell) with a consensus price target of $2.42, while recent broker targets cluster around $1.50–$1.60.
• The latest quarter slightly beat estimates — ($0.06) EPS vs. ($0.07) est. and $82.37M revenue vs. $78.07M est. — but the company remains unprofitable (negative net margin and ROE), carries high leverage (debt/equity ~3.94), and has a market cap of about $117.7M.

The Beauty Health Company (NASDAQ:SKIN - Get Free Report) dropped 1.1% during trading on Thursday . The stock traded as low as $0.9003 and last traded at $0.9215. Approximately 289,935 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 688,237 shares. The stock had previously closed at $0.9318.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on SKIN. Canaccord Genuity Group reissued a "hold" rating and issued a $1.50 target price on shares of Beauty Health in a research report on Friday, March 13th. Zacks Research raised Beauty Health from a "strong sell" rating to a "hold" rating in a research report on Monday, March 16th. Jefferies Financial Group reissued a "hold" rating and issued a $1.60 target price on shares of Beauty Health in a research report on Wednesday, January 14th. Benchmark reissued a "hold" rating on shares of Beauty Health in a research report on Friday, March 13th. Finally, TD Cowen dropped their target price on Beauty Health from $1.65 to $1.50 and set a "hold" rating on the stock in a research report on Monday, March 16th. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Beauty Health has an average rating of "Hold" and a consensus price target of $2.42.

Beauty Health Trading Down 1.1%

The stock has a fifty day moving average of $1.08 and a 200 day moving average of $1.35. The company has a debt-to-equity ratio of 3.94, a quick ratio of 1.40 and a current ratio of 1.66. The company has a market capitalization of $117.74 million, a PE ratio of -4.61 and a beta of 1.24.

Beauty Health (NASDAQ:SKIN - Get Free Report) last posted its earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. The firm had revenue of $82.37 million during the quarter, compared to analyst estimates of $78.07 million. Beauty Health had a negative net margin of 3.16% and a negative return on equity of 15.40%. As a group, sell-side analysts predict that The Beauty Health Company will post -0.25 earnings per share for the current fiscal year.

Institutional Trading of Beauty Health

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Woodline Partners LP grew its position in Beauty Health by 255.9% in the 3rd quarter. Woodline Partners LP now owns 5,930,027 shares of the company's stock valued at $11,801,000 after acquiring an additional 4,263,997 shares during the last quarter. Millennium Management LLC grew its position in Beauty Health by 127.0% in the 4th quarter. Millennium Management LLC now owns 5,764,802 shares of the company's stock valued at $8,013,000 after acquiring an additional 3,225,668 shares during the last quarter. Mirabella Financial Services LLP grew its position in Beauty Health by 21.3% in the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company's stock valued at $31,037,000 after acquiring an additional 2,734,728 shares during the last quarter. Soleus Capital Management L.P. bought a new position in Beauty Health in the 2nd quarter valued at $1,910,000. Finally, Geode Capital Management LLC grew its position in Beauty Health by 27.5% in the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company's stock valued at $4,399,000 after acquiring an additional 496,963 shares during the last quarter. Hedge funds and other institutional investors own 93.26% of the company's stock.

About Beauty Health

Beauty Health Company NASDAQ: SKIN is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health's brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.